Transgene and BioInvent Announce Compelling Preclinical Data For BT-001 in Solid Tumors
BT-001 is a novel Invir.IO® based oncolytic virus expressing a Treg-depleting anti-CTLA4 antibody and the cytokine GM-CSF Broad antitumor activity…
Pharmaceuticals, Biotechnology and Life Sciences
BT-001 is a novel Invir.IO® based oncolytic virus expressing a Treg-depleting anti-CTLA4 antibody and the cytokine GM-CSF Broad antitumor activity…
– The submission is based on positive results from the Phase III POLYP 1 and POLYP 2 studies of Xolair…
All subjects successfully self-administered a mini dose of RTU glucagon Rebound hypoglycemia observed more frequently in the placebo arm and…
All subjects successfully self-administered a mini dose of RTU glucagon Rebound hypoglycemia observed more frequently in the placebo arm and…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement,…
LONDON–(BUSINESS WIRE)–#cytomegalovirustherapeutics–Technavio has been monitoring the global cytomegalovirus (CMV) therapeutics market and the market is poised to grow by USD…
LONDON–(BUSINESS WIRE)–#cancercachexiatherapeutics–The global cancer cachexia therapeutics market is expected to grow by USD 568.85 million during 2019-2023, progressing at a…
DUBLIN–(BUSINESS WIRE)–The “Solvent Evaporation Market by Evaporator Type (Rotary Evaporator, Nitrogen Blow Down Evaporator, Centrifugal Evaporator), End-User (Pharmaceutical & Biopharmaceutical,…
Daniel W. Armstrong and Szabolcs Fekete will be honored at the Pittcon 2020 conference. CRANBURY, N.J.–(BUSINESS WIRE)–#pittcon—LC GC®, a leading…